Technology:
Immunotherapy
Headquarters:
New York, United States
Investment Stage:
N/A
Founded Date:
2005
Estimated Revenue:
$1M to $10M
Employee Number:
11-50
Total Funding:
N/A
Industry:
PharmTech
Investor Type:
N/A